Abstract
This article has a mistake.
| Original language | English |
|---|---|
| Pages (from-to) | 510 |
| Number of pages | 1 |
| Journal | Journal of Microbiology, Immunology and Infection |
| Volume | 52 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Jun 2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Immunology and Allergy
- General Immunology and Microbiology
- Microbiology (medical)
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Corrigendum to “Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia” (Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia (2017) 50(4) (547–548), (S1684118216300299), (10.1016/j.jmii.2016.03.008))'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS